MoneyWorks4Me

Dishman Carbogen Amcis informs about company updates

11 Oct 2017 Evaluate

Pursuant to Regulation 13(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), Dishman Carbogen Amcis has submitted a statement regarding status of Investors Complaints for the quarter ended 30th September, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..